Ceribell (CBLL) Non-Current Assets (2023 - 2026)
Ceribell (CBLL) posted Non-Current Assets of $9.2 million for Q1 2026, up 0.9% on a QoQ basis from $9.1 million in Q4 2025, and up 13.86% year-over-year from $8.1 million in Q1 2025.
Ceribell (CBLL) Non-Current Assets (2023 - 2026) Analysis & Trends
Ceribell's Non-Current Assets history runs 4 years deep, the most recent figure standing at $9.2 million for Q1 2026.
- Quarterly Non-Current Assets rose 13.86% year-over-year to $9.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $33.9 million (down 3.9% YoY) and the FY2025 annual result came in at $9.1 million, up 11.61% from the prior year.
- Non-Current Assets was $9.2 million for Q1 2026 at Ceribell, up from $9.1 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $12.1 million in Q3 2024 and bottomed at $7.0 million in Q4 2023.
- A 4-year average of $8.6 million and a median of $8.1 million in 2024 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2024 — Non-Current Assets advanced 16.97% — and 2025, when it sank 36.2%.
- Ceribell's Non-Current Assets stood at $7.0 million in 2023, then grew by 16.97% to $8.1 million in 2024, then rose by 11.61% to $9.1 million in 2025, then gained by 0.9% to $9.2 million in 2026.
- Business Quant data shows CBLL's Non-Current Assets at $9.2 million in Q1 2026, $9.1 million in Q4 2025, and $7.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.30 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 20.47 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 26.70 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 6.35 Bn |
| 10 | Ceribell | 613.16 Mn | 471.97 Mn | 23.12 Mn | 9.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.17 Mn |
| Dec 31, 2025 | 9.09 Mn |
| Sep 30, 2025 | 7.72 Mn |
| Jun 30, 2025 | 7.90 Mn |
| Mar 31, 2025 | 8.05 Mn |
| Dec 31, 2024 | 8.14 Mn |
| Sep 30, 2024 | 12.10 Mn |
| Dec 31, 2023 | 6.96 Mn |